| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |